FLEXBLOK - Accelerate Biotech Innovation

Accelerate Biotech Innovation

via Transparent, Trusted, and Secure Data Collaboration

Biotech's greatest breakthroughs are stalled not by scientific limits, but by organizational silos. Our enterprise-grade Blockchain-as-a-Service fosters trust and seamless collaboration to unlock progress.

Get Free Use cases
No sales conversation just pure tailored insights

We understand your journey

1/5,000

drugs reach the market out of thousands of potential compounds

10+

years average development from discovery to market approval

$2.6B

average cost per drug including failed attempts and regulatory costs

The Traditional Journey
discovery
Discovery

2-5 years

100%
pre-clinical
Preclinical

3-6 years

12%
phase1
Clinical Trials

6-9 years

5%
phase2
Regulatory Approval

1-2 years

1%

success-
rate

What’s Really
Causing the Delays?

broken
Broken
collaboration
broken
Unclear
data
broken
Compliance
gaps
Drug Discovery & Research
Clinical Development
Commercialization

Drug Discovery & Preclinical Research

Your scientists are close to a breakthrough in AI-driven biomarker discovery. But progress stalls, not due to research, but due to datasets lacking clear, traceable provenance. This isn't a technical hiccup. It's a systemic risk.

Critical Challenges

Regulatory Approval Risk
Auditors and regulatory bodies demand traceability, accountability, and ethical compliance.
Vulnerable research integrity
Fragmented consent records, incomplete processing histories, and missing metadata expose your work to invalidation.
Preclinical Replicability
Disconnected data undermines reproducibility, threatening scientific and financial credibility.
Biobank Oversight
Unverifiable consent and access logs expose your research to regulatory fines and public distrust.
Erosion of trust
The inability to prove data integrity erodes trust among donors, ethics boards, collaborators, and funders.
Compromised Sample Integrity
Genetic samples lacking verifiable provenance regarding their origin, consent, and handling history introduce fundamental uncertainty into subsequent research and actions.

The Solution

A unified clinical trial ecosystem where patient consent is dynamically managed, data from all sources is harmonized in real-time, and every event is immutably logged, creating a single source of clinical truth that:

rocket
Accelerates AI
readiness
insurance
Ensures
compliance
safeguard
Safeguards IP
like
Reinforces
stakeholder trust

Clinical Development

Modern clinical trials are complex, data-heavy, and multi-centered, requiring trust, transparency, and operational integrity across sponsors, CROs, investigators, patients, and regulators. Sustaining this trust across stakeholders remains a core industry challenge.

Critical Challenges

Patient mistrust
Lack of trust in data privacy, especially among diverse groups, significantly impedes clinical trial enrollment. Without transparent and verifiable data mechanisms, recruitment suffers, delaying timelines and undermining the generalizability of drug efficacy.
Fragmented Data
Critical data scattered across disparate systems (EDC, CRO databases) creates inefficiencies, leading to critical decisions based on incomplete information. This results in costly errors, audit findings, and delayed regulatory submissions.
Inefficient Consent Management
Traditional paper-based consent limits patient control and transparency over data use. This restricts recruitment efforts and reduces inclusivity crucial for representative clinical evidence.
Expensive re-trials
Maintaining protocol adherence and data integrity is paramount. Deviations, entry errors, and consent management issues compromise data quality, potentially invalidating trial sites, forcing expensive re-trials, and directly impacting approval pathways.
Regulatory Audit Risks
Incomplete documentation, fragmented audit trails, and cross-system data inconsistencies heighten exposure to regulatory findings. Such gaps undermine data credibility, delay marketing authorizations, and compromise the acceptability of clinical evidence by health authorities.

The Solution

A unified clinical trial ecosystem where patient consent is dynamically managed, data from all sources is harmonized in real-time, and every event is immutably logged, creating a single source of clinical truth that:

rocket
Fosters patient trust and accelerates recruitment
insurance
Ensures data integrity across all trial sources
safeguard
Streamlines regulatory audits and submissions
like
Empowers investigators with complete, real-time data

Commercialization

Post-launch drug recalls due to supply chain issues can cripple manufacturers. Siloed, fragmented data across vendors hinders traceability, raising compliance risks and revenue loss due to lack of visibility and delayed response.

Critical Challenges

Supply Chain Opacity & Counterfeit Risk
Traditional pharmaceutical supply chains that lack granular, end-to-end visibility are vulnerable to counterfeits. This endangers patients, exposes your company to massive liability, and undermines years of R&D investment.
Maintaining Cold Chain Integrity
For biologics, an unverifiable break in the cold chain compromises efficacy and safety. This failure results in ineffective drugs, wasted inventory, and a direct threat to patient health and your company's financial stability.
Inefficient Recall Management
The inability to quickly and precisely trace affected batches due to fragmented tracking systems severely hampers recall efforts, amplifying public health risks, increasing financial penalties, and severely damaging your market standing.

The Solution

A transparent supply chain where every handover, temperature log, and quality check is captured on an immutable, shared ledger, creating a digital passport for every product that:

rocket
Enables rapid, precise, and targeted recalls
insurance
Fortifies patient safety and protects brand value
safeguard
Guarantees product authenticity, eliminates counterfeits
like
Ensures end-to-end cold chain integrity

Blockchain: Powering Next‑Gen Biotech Breakthroughs

A typical biotech journey spans years. Delays mean lost revenue and slower access to critical therapies.
But what if you could shorten that timeline by even four months?

timeline1
Extend Market
Exclusivity

Secure additional months of patent-protected sales, directly impacting top-line revenue

timeline2
Enhance Drug
Success Rates

Improve the probability of successful phase progression through superior data integrity and faster, more confident go/no-go decisions.

timeline3
Accelerate Time-to-Patient

Shorten the clinical-to-market timeline to deliver critical therapies to patients months ahead of schedule.

Biotech-Centric
Architecture

Ensure all data, from research to clinical trials and supply chain logs, is tamper-proof, timestamped, and fully traceable.

Built-In Regulatory
Compliance

Provides immediate compliance readiness with integrated support for industry regulations, minimizing operational risks and boosting stakeholder confidence.

Fast & Seamless
Integration

Connects with existing systems (LIMS, ERP, EDC) via developer-friendly APIs, enabling go-live in days, not months.

reason

Blockchain-Powered Trust
for Verifiable Biotech

Your workflow doesn't change. Its integrity and verifiability do

FLEXBLOK is an enterprise-grade private blockchain-as-a-service platform that works with your existing systems. Think of it as the secure backbone that connects and validates the data your team relies on every day, making your processes inherently audit-ready.

Establish Unshakeable Data Integrity

Ensure all data, from research to clinical trials and supply chain logs, is tamper-proof, timestamped, and fully traceable.

Foster Trust-Based Collaboration

Enable secure, permissioned data sharing with internal teams, CROs, and academic partners, complete with an audit trail.

Automate and Streamline Compliance

Automate trial milestones and patient consent with smart contracts to reduce manual oversight and ensure audit readiness.

Accelerate Your Timelines

FLEXBLOK reduces data management friction and enhances collaboration, speeding up development cycles to bring innovations to market faster.

Case Studies & Use cases

Swipe or to navigate

End-to-End Data Integrity in Clinical Trials

Clinical trial data silos compromise integrity and GCP compliance. FLEXBLOK provides the solution by unifying data on an immutable ledger for biotech organizations, ensuring data provenance, streamlining multi-site trials, and accelerating the path to regulatory approval.

Patient-Centric

Empowers patients with full control over their data

Unified Ecosystem

A single, transparent platform for all stakeholders.

Immutable Audit Trail

Guarantees data integrity for R&D and compliance.

Secure Patient Identity Management

Securing patient identity against data breaches is a critical healthcare challenge. FLEXBLOK Blockchain-as-a-Service platform uses Decentralized Identifiers (DIDs) and token-gated access to create a sovereign health identity, giving patients full control over who accesses their encrypted medical records.

Rapid Deployment

Foundational infrastructure live in eight weeks.

Verifiable Chain of Custody

An immutable, auditable log for every sample's journey.

Enhanced Research Credibility

Empowers researchers with undisputed data provenance.

Verifiable Sample Integrity for Biobanking

Provenance gaps in biobanking create significant risks, undermining research validity and delaying breakthroughs. FLEXBLOK provides an immutable ledger to ensure sample integrity from collection to analysis, deploying the core infrastructure for a leading Academic research consortium for lymphoma treatments and diagnostics in just eight weeks.

Sovereign Health Identity

A portable, verifiable digital identity for every patient.

Consent-Driven Access

Patients control all data access via smart contracts.

Breach-Resistant Storage

Encrypted health records on a decentralized network.

1 2 3

Fuel Your Next Innovation, Not Your Legacy System Overheads

FLEXBLOK enables biotech teams to meet evolving industry demands with speed, security, and simplicity, without needing blockchain expertise.

Let’s talk through your biotech challenge, and show you how FLEXBLOK delivers.

What Industry Leaders Are Saying About FLEXBLOK?

We required a verifiable traceability system for our lymphoma samples without a long, complex build-out. Flexblok provided a low-cost, production-ready infrastructure in under eight weeks.

CTO

Europe’s Leading Academic Research Consortium

Our research process was constantly slowed down by teams working with different data. We’re so thankful to finally have one shared, trusted Infrastructure for everything, as it lets our scientists focus on the science, not the data.

CMO

French biotech developing precision antibody‑drug conjugates

We were seeing increasingly sophisticated check fraud attempts across our network. It’s a significant relief to have the platform's digital notary function, to provide the concrete, transaction-level proof needed to effectively mitigate those threats.

CEO

U.S. based Start-Up Specializing in Check Cashing

Manual data gathering for regulatory audits was a major resource drain for our quality team. This platform's ability to create and maintain an immutable, real-time audit trail has been a significant operational improvement.

CTO

Leading U.S.-Based Pharmaceutical

Our process for verifying training data was taking up way too much of the team's time. We needed to log everything without ripping apart our pipeline. FLEXBLOK's APIs helped us create that verifiable history for every dataset, and now our team can access it in real time.

Lead Engineer

UK-Based AI Orchestration Platform

The platform itself is powerful, but what stood out was the support during integration. The team felt like an extension of our own, responsive, knowledgeable, and genuinely invested in getting it right. That kind of partnership is rare.

CTO

A New York-based SaaS company

Frequently asked questions

Everything you need to know about the product and billing.

How is blockchain technology used in the biotech industry?
Blockchain enables secure and transparent systems for clinical trials, IP licensing, supply chain tracking, and compliance documentation. It helps biotech companies maintain tamper-proof, real-time records across complex workflows.
Why do biotech companies need blockchain?
Traditional data systems are siloed, vulnerable to tampering, and expensive to manage. Blockchain empowers biotech companies with audit-ready transparency, secure data sharing, and automated compliance which is critical for innovation and global collaboration.
Is blockchain secure enough for biotech data compliance?
Yes. FLEXBLOK Blockchain as a service platform, support industry-standard compliance frameworks to ensure all biotech data remains secure, traceable, and audit-ready from day one.
Do we need our own blockchain infrastructure, blockchain engineers, and will there be gas fees with FLEXBLOK?
No. FLEXBLOK is a managed Blockchain-as-a-Service (BaaS) operating on a private blockchain, so you don't need your own infrastructure or blockchain engineers. Our ready APIs and low-code tools allow your existing team to integrate quickly. Importantly, FLEXBLOK uses a subscription model with no unpredictable gas fees.

How does blockchain improve clinical trials?
Absolutely. Blockchain secures every stage of the trial lifecycle, from patient consent to results improving trust, reducing audit time, and accelerating regulatory approvals through better traceability.
Scroll to Top